SHSE:600513 (China)
Â
Class A
Â¥
10.52
(+1.15%)
Nov 28
Business Description
Jiangsu Lianhuan Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000001DP6
Share Class Description:
SHSE:600513: Class ACompare
Compare
Traded in other countries / regions
600513.China IPO Date
2003-03-19Description
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 3.94 | |||||
| Interest Coverage | 7.58 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.57 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16 | |||||
| 3-Year EBITDA Growth Rate | 12.5 | |||||
| 3-Year EPS without NRI Growth Rate | 2.7 | |||||
| 3-Year FCF Growth Rate | 21.5 | |||||
| 3-Year Book Growth Rate | 8.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.92 | |||||
| 9-Day RSI | 55.05 | |||||
| 14-Day RSI | 56.19 | |||||
| 6-1 Month Momentum % | 9.16 | |||||
| 12-1 Month Momentum % | -20.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.71 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 106.15 | |||||
| Days Sales Outstanding | 78.8 | |||||
| Days Payable | 79.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.44 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 21.3 | |||||
| Forward Dividend Yield % | 1.44 | |||||
| 5-Year Yield-on-Cost % | 2.94 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | -2.24 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.07 | |||||
| Operating Margin % | 9.13 | |||||
| Net Margin % | 5.95 | |||||
| FCF Margin % | 0.25 | |||||
| ROE % | 10.17 | |||||
| ROA % | 4.81 | |||||
| ROIC % | 7.72 | |||||
| ROC (Joel Greenblatt) % | 12.08 | |||||
| ROCE % | 13.07 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.98 | |||||
| PE Ratio without NRI | 21.53 | |||||
| Shiller PE Ratio | 30.79 | |||||
| PEG Ratio | 1.14 | |||||
| PS Ratio | 1.31 | |||||
| PB Ratio | 2.15 | |||||
| Price-to-Tangible-Book | 2.59 | |||||
| Price-to-Free-Cash-Flow | 1758.33 | |||||
| Price-to-Operating-Cash-Flow | 15.75 | |||||
| EV-to-EBIT | 17.19 | |||||
| EV-to-EBITDA | 17.19 | |||||
| EV-to-Revenue | 1.53 | |||||
| EV-to-FCF | 610.74 | |||||
| Price-to-Median-PS-Value | 0.61 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.52 | |||||
| Price-to-Graham-Number | 1.57 | |||||
| Earnings Yield (Greenblatt) % | 5.82 | |||||
| FCF Yield % | 0.19 | |||||
| Forward Rate of Return (Yacktman) % | 11.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Lianhuan Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,335.273 | ||
| EPS (TTM) (Â¥) | 0.48 | ||
| Beta | 0.98 | ||
| Volatility % | 46.5 | ||
| 14-Day RSI | 56.19 | ||
| 14-Day ATR (Â¥) | 0.453298 | ||
| 20-Day SMA (Â¥) | 10.491 | ||
| 12-1 Month Momentum % | -20.51 | ||
| 52-Week Range (Â¥) | 6.71 - 14.28 | ||
| Shares Outstanding (Mil) | 285.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Lianhuan Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Lianhuan Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangsu Lianhuan Pharmaceutical Co Ltd Frequently Asked Questions
What is Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513)'s stock price today?
The current price of SHSE:600513 is ¥10.52. The 52 week high of SHSE:600513 is ¥14.28 and 52 week low is ¥6.71.
When is next earnings date of Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513)?
The next earnings date of Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513) is .
Does Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513) pay dividends? If so, how much?
The Dividend Yield %  of Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513) is 1.44% (As of Today), Highest Dividend Payout Ratio of Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513) was 0.38. The lowest was 0.21. And the median was 0.27. The  Forward Dividend Yield % of Jiangsu Lianhuan Pharmaceutical Co Ltd(SHSE:600513) is 1.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers